Langton Labs - Investor Profile and Portfolio

Innovating diabetes management with automated bionic pancreas technology. The company pioneers the development of the iLet Bionic Pancreas, an insulin delivery system designed to simplify diabetes management. This innovative technology reduces the burden of decision-making for individuals with diabetes by automating insulin dosing based on continuous glucose monitoring data. The system learns individual insulin needs, eliminating the need for manual carb counting and corrections. The company is dedicated to improving the lives of people with diabetes through user-friendly technological solutions. They focus on creating a supportive community and providing resources for both patients and healthcare professionals. Their commitment extends to ongoing research, clinical trials, and continuous product development to enhance the effectiveness and accessibility of their bionic pancreas system. The company is focused on social impact by making diabetes management easier.

Cloud-based suite solutions for applicant tracking. It offers an integrated system to manage the entire hiring process, from sourcing candidates to scheduling interviews and onboarding new hires. It includes job board integrations with platforms like Indeed and ZipRecruiter, as well as features like automated interview scheduling and video cover letters for pre-screening candidates.

Manufacturer of spacecraft propulsion hardware, thrusters, modules, and propulsion systems. The company supplies thrusters individually or integrated into multi-thruster modules. It also incorporates them into complete turn-key propulsion systems. Custom design services and manufacturing are available for unique application requirements. The company focuses on safer, low-toxicity propulsion and cost-consciousness. It maintains quality and reliability in flight qualified aerospace hardware.